Serum myeloid-related protein 8/14 is a potential predictor of diabetic kidney disease

Wensha Gu1, Jingxiang Cui2,3,4, Min Shi1

  • 1Departments of Endocrinology and ICU, the Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu 223300, China.

Discovery Medicine
|December 31, 2020
PubMed
Abstract

Insights

Serum myeloid-related protein 8/14 (MRP8/14) levels increase with diabetic kidney disease (DKD) progression. MRP8/14 may serve as an independent predictor for DKD advancement.

Area of Science:

  • Nephrology
  • Immunology
  • Endocrinology

Background:

  • Diabetic kidney disease (DKD) is a major complication of diabetes, characterized by chronic vascular inflammation.
  • Myeloid-related protein 8/14 (MRP8/14), secreted by macrophages, is linked to vascular inflammation.

Purpose of the Study:

  • To investigate the association between serum MRP8/14 levels and the progression of diabetic kidney disease (DKD).

Main Methods:

  • 80 individuals with type 2 diabetes were stratified into four groups based on urinary albumin/creatinine ratio (ACR).
  • Serum MRP8/14 concentrations were quantified using ELISA.
  • Clinical variables including BMI, serum creatinine (Cre), blood urea nitrogen (BUN), systolic blood pressure (SBP), and estimated glomerular filtration rate (eGFR) were collected.

Main Results:

  • Serum MRP8/14 levels showed a significant positive correlation with ACR, BMI, Cre, BUN, and SBP.
  • A significant negative correlation was observed between serum MRP8/14 and eGFR.
  • Logistic regression identified age, Cre, eGFR, ACR, and MRP8/14 as factors associated with DKD progression.

Conclusions:

  • Serum MRP8/14 is significantly correlated with the progression of diabetic kidney disease (DKD).
  • MRP8/14 shows potential as an independent predictive biomarker for DKD progression.

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
81
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
193
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
82
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
357
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
354